Following the news that UK Leading British Medical Cannabis and CBD Company, Cannaray, have announced the first UK medical cannabis prescription, does this mean that prescriptions could soon be available in Taunton?
Following a £7.8 million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company.
Cannaray this week, have announced the fulfilment of its first Medical Cannabis prescription in the UK. The fulfilment, which has been prescribed to Jorja Emerson, a three-year-old British girl who suffers from severe epilepsy, demonstrates a real progression in the quest to allow patients to access pioneering treatments of Medical Cannabis.
In collaboration with one of the world’s largest Cannabis companies Aphria Inc, Cannaray was able to fulfil this prescription. Aphria has novel cannabis formulations and delivery systems that are to European medical standards which are currently not available from other sources for UK patients.
With a Series A funding round securing the backing of £7.8 million, Cannaray is pleased to be able to mark this significant milestone with Jorja’s prescription, cementing its position as one of Europe’s leading Medical Cannabis and CBD company.
Cannaray CEO, Scott Maguire has told Tone News:
“Working with the medical community to provide specialist support and access to cannabis-based drugs for patients in dire need of this treatment is fundamental to our strategy. We are pleased to assist Robin in accessing treatment for his daughter and we will continue to drive for broader and continuous cannabis access for patients.”
Cannaray’s brand mission is to make a positive impact on global health while simultaneously working to professionalise the industry with products that offer tangible benefits. Consumers are currently aware of the therapeutic benefits of cannabis, but cannot easily access quality solutions.